Ioannis Boletis Selected Research

Ioannis Boletis Research Topics

Disease

4	Chronic Kidney Failure (Chronic Renal Failure) 08/2022 - 11/2013
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 05/2023 - 02/2011
3	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2020 - 02/2011
2	Infections 02/2023 - 06/2021
2	Vasculitis (Vasculitides) 05/2022 - 01/2007
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2021 - 02/2011
2	Respiratory Insufficiency (Respiratory Failure) 06/2021 - 07/2020
2	Glomerulonephritis 05/2021 - 01/2007
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021 - 02/2011
2	Neoplasms (Cancer) 05/2020 - 05/2007
2	Immunoglobulin Light-chain Amyloidosis 01/2017 - 06/2012
1	Lupus Nephritis 09/2023
1	Frailty 02/2023
1	Chronic Renal Insufficiency 08/2022
1	Hypertension (High Blood Pressure) 08/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 05/2022
1	Pathologic Complete Response 05/2022
1	Shock 01/2022
1	COVID-19 12/2021
1	Proteinuria 08/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 06/2021
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2020
1	Acute Kidney Injury (Acute Renal Failure) 09/2020
1	Abdominal Aortic Aneurysm 06/2013
1	Sclerosis 01/2013
1	Pulmonary Hypertension 01/2013
1	Arteriovenous Fistula 01/2013
1	Amyloidosis 06/2012
1	Inflammation (Inflammations) 01/2007
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2007
1	Pathologic Processes 01/2007

Drug/Important Bio-Agent (IBA)

3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 01/2007
2	Calcineurin InhibitorsIBA 01/2019 - 05/2007
2	Bortezomib (Velcade)FDA Link 01/2017 - 06/2012
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 01/2007
1	MicroRNAs (MicroRNA)IBA 09/2023
1	Axitinib (AG 013736)IBA 05/2023
1	Penicillamine (Cuprimine)FDA Link 05/2023
1	pembrolizumabIBA 05/2023
1	Tamoxifen FDA LinkGeneric 05/2023
1	Rituximab (Mabthera)FDA Link 05/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	BNT162 VaccineIBA 12/2021
1	VaccinesIBA 12/2021
1	mRNA VaccinesIBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	Serum AlbuminIBA 08/2021
1	Antiphospholipid AntibodiesIBA 12/2020
1	AntibodiesIBA 05/2020
1	AutoantibodiesIBA 05/2020
1	Phospholipase A2 ReceptorsIBA 05/2020
1	Glycoproteins (Glycoprotein)IBA 05/2020
1	Immunoglobulin FragmentsIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2012
1	Lenalidomide (CC 5013)FDA Link 06/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012
1	podocalyxinIBA 02/2011
1	Sirolimus (Rapamycin)FDA Link 05/2007
1	Everolimus FDA Link 05/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2007
1	TOR Serine-Threonine KinasesIBA 05/2007
1	Matrix Metalloproteinases (MMPs)IBA 01/2007

Therapy/Procedure

8	Kidney Transplantation 02/2023 - 05/2007
4	Therapeutics 05/2023 - 05/2020
2	Transplantation 02/2023 - 08/2022
2	Artificial Respiration (Mechanical Ventilation) 06/2021 - 07/2020
1	Liver Transplantation 02/2023
1	Immunotherapy 02/2023
1	Plasmapheresis 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2020
1	Aftercare (After-Treatment) 01/2017
1	Stents 06/2013
1	Endovascular Aneurysm Repair 06/2013
1	Renal Dialysis (Hemodialysis) 01/2013
1	Microbubbles 01/2013
1	Peritoneal Dialysis 01/2013